Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a ...

Novartis said in a statement to Reuters that evolving laws ... Businesscategory China's vice premier meets Blackstone ...

The finance sector is strongly represented in this year's attendees. HSBC Group Chief Executive Georges Elhedery is on the ...

Blackstone Inc. secured about $8 billion in capital commitments for a new real estate debt fund, the latest effort to seize on dislocations in the property market. Blackstone Real Estate Debt ...

US investment giant Blackstone is negotiating to acquire South City, eastern India's largest mall, for around Rs 3,500 crore. Talks are at an advanced stage, and the deal might include a property ...

For the second time in five years, Blackstone notched a record for a commercial property debt fundraise. The investment giant closed on an $8 billion commercial real estate debt fund this week ...

In this article, we are going to take a look at where Blackstone Inc. (NYSE:BX) stands against other big-cap stocks that are plunging so far in 2025. The market has been reversing its gains ...

A real estate investment trust sponsored by asset manager Blackstone Group and Bengaluru developer Sattva Group filed its draft papers with the market regulator for an initial public offering (IPO ...

Blackstone closed this week on an $8 billion commercial real-estate debt fund, matching the record for this type of investment vehicle and offering another sign of a property-market rebound. The ...

Novartis (NVS) shareholders agreed to the board of directors’ recommendations for all proposed resolutions at the company’s Annual General Meeting, the company announced. “With a dividend ...

Blackstone (BX) recently closed on an $8B commercial real-estate debt fund, offering a sign of a property-market rebound, Peter Grant of The Wall Street Journal reports. The firm took two years to ...

A total of 1,693 shareholders were present at the meeting held in Basel, representing approximately 57.42% of the issued shares of Novartis. With a dividend increase of 6.1% to CHF 3.50 per share, ...